BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 18256672)

  • 1. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
    Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
    Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
    Takaoka A; Wang Z; Choi MK; Yanai H; Negishi H; Ban T; Lu Y; Miyagishi M; Kodama T; Honda K; Ohba Y; Taniguchi T
    Nature; 2007 Jul; 448(7152):501-5. PubMed ID: 17618271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
    Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
    Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
    Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
    Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular detection and immune signaling pathways of DNA vaccines.
    Tang CK; Pietersz GA
    Expert Rev Vaccines; 2009 Sep; 8(9):1161-70. PubMed ID: 19722890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular DNA sensors in immunity.
    Takeshita F; Ishii KJ
    Curr Opin Immunol; 2008 Aug; 20(4):383-8. PubMed ID: 18573338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune control of nucleic acid-based vaccine immunogenicity.
    Koyama S; Coban C; Aoshi T; Horii T; Akira S; Ishii KJ
    Expert Rev Vaccines; 2009 Aug; 8(8):1099-107. PubMed ID: 19627190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A FADD-dependent innate immune mechanism in mammalian cells.
    Balachandran S; Thomas E; Barber GN
    Nature; 2004 Nov; 432(7015):401-5. PubMed ID: 15549108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The innate immune response to DNA.
    Vilaysane A; Muruve DA
    Semin Immunol; 2009 Aug; 21(4):208-14. PubMed ID: 19497760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune recognition of, and regulation by, DNA.
    Ishii KJ; Akira S
    Trends Immunol; 2006 Nov; 27(11):525-32. PubMed ID: 16979939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rainbow trout TLR9 gene and its role in the immune responses elicited by a plasmid encoding the glycoprotein G of the viral haemorrhagic septicaemia rhabdovirus (VHSV).
    Ortega-Villaizan M; Chico V; Falco A; Perez L; Coll JM; Estepa A
    Mol Immunol; 2009 May; 46(8-9):1710-7. PubMed ID: 19272649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
    Aurisicchio L; Peruzzi D; Conforti A; Dharmapuri S; Biondo A; Giampaoli S; Fridman A; Bagchi A; Winkelmann CT; Gibson R; Kandimalla ER; Agrawal S; Ciliberto G; La Monica N
    Clin Cancer Res; 2009 Mar; 15(5):1575-84. PubMed ID: 19240169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D
    Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recognition mechanism of pathogen-associated molecular patterns and role of innate immune lymphocytes in fungal infection].
    Kawakami K
    Rinsho Byori; 2009 Aug; 57(8):779-85. PubMed ID: 19764413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines for the prevention and treatment of allergy.
    Chua KY; Kuo IC; Huang CH
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):50-4. PubMed ID: 19532092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.
    Wheeler M; Cortez-Gonzalez X; Frazzi R; Zanetti M
    Int Rev Immunol; 2006; 25(3-4):83-97. PubMed ID: 16818366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
    Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
    Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.